Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.86%-508.52K | -718.38%-104.06K | -38.06%176.88K | 94.75%-24.47K | -1.16%-76.2K | 45.28%-250.67K | 184.20%16.83K | 225.40%285.58K | 57.56%-465.62K | 51.38%-75.33K |
| Net income from continuing operations | -133.22%-200.68K | 26.52%-177.01K | 16.12%-363.37K | -110.04%-1.37M | -911.86%-1.3M | 1,086.13%604.05K | 4.71%-240.91K | -33.95%-433.23K | 62.41%-654.18K | 26.23%-128.87K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---349.11K | ---104.29K |
| Depreciation and amortization | 0.00%100 | -1.00%99 | 1.01%100 | -0.25%399 | 0.00%100 | 0.00%100 | 0.00%100 | -1.00%99 | 0.25%400 | 0.00%100 |
| Asset impairment expenditure | ---- | ---- | ---- | --5.02K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 42,915.27%117.74K | 5.34%60.25K | -56.45%66.18K | 5,021.52%390.33K | 137.46%181.43K | -100.15%-275 | -61.75%57.2K | 7.17%151.97K | -101.51%-7.93K | -105.93%-484.3K |
| Change In working capital | 50.19%-425.69K | -93.71%12.6K | -16.37%473.97K | 386.41%953.82K | 255.45%1.04M | -90.19%-854.55K | 140.89%200.44K | 110.47%566.74K | 68.43%196.09K | 14.94%292.92K |
| -Change in receivables | ---- | ---- | ---- | -62.00%10K | ---- | ---- | ---- | ---- | 172.47%26.32K | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | ---8K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 666.02%498.27K | ---- | ---- | ---- | ---- | -130.95%-88.03K | ---- |
| -Change in other current assets | --0 | --2K | ---2K | ---- | ---- | -3,560,000.00%-35.6K | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | 48.02%-425.69K | -94.71%10.6K | -16.02%475.97K | ---- | ---- | -82.27%-818.95K | 162.88%200.44K | 136.22%566.74K | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | 75.93%453.55K | ---- | ---- | ---- | ---- | 248.77%257.8K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -102.86%-508.52K | -718.38%-104.06K | -38.06%176.88K | 94.75%-24.47K | -1.16%-76.2K | 45.28%-250.67K | 184.20%16.83K | 225.40%285.58K | 57.56%-465.62K | 51.38%-75.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -49.08K | -112.17K | 0 | 0 | 0 | 0 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | ---49.08K | ---112.17K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---49.08K | ---112.17K | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 25,847.97%326.17K | 2,284.05%197.68K | 1,914.17%190.33K | -102.94%-14.3K | -95.85%3.99K | -99.68%1.26K | -185.70%-9.05K | -170.04%-10.49K | 18.29%487.07K | 398.63%95.98K |
| Net issuance payments of debt | 25,847.97%326.17K | 2,284.05%197.68K | 2,341.49%190.33K | -103.18%-12.3K | 129.97%3.99K | -99.69%1.26K | -440.36%-9.05K | ---8.49K | -14.34%386.67K | 36.52%-13.31K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 1,078.52%109.28K | ---- |
| Net other financing activities | ---- | ---- | ---- | 77.47%-2K | --0 | --0 | --0 | 48.52%-2K | 68.80%-8.88K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 25,847.97%326.17K | 2,284.05%197.68K | 1,914.17%190.33K | -102.94%-14.3K | -95.85%3.99K | -99.68%1.26K | -185.70%-9.05K | -170.04%-10.49K | 18.29%487.07K | 398.63%95.98K |
| Net cash flow | ||||||||||
| Beginning cash position | -13.05%294.71K | -10.54%287.97K | 35.03%33.04K | -3.17%24.47K | 194.04%69.97K | 349.42%338.95K | 196.48%321.9K | -3.17%24.47K | -96.47%25.27K | -86.71%23.8K |
| Current changes in cash | 26.89%-182.36K | 472.62%44.53K | -7.29%255.04K | -280.72%-38.77K | -449.74%-72.22K | -316.21%-249.42K | 133.59%7.78K | 227.96%275.09K | 103.12%21.45K | 111.74%20.65K |
| Effect of exchange rate changes | 267.77%32.82K | -507.65%-37.79K | -100.51%-113 | 312.74%47.34K | 276.70%35.29K | -335.60%-19.56K | 192.66%9.27K | 3,971.23%22.34K | -970.79%-22.25K | -190.09%-19.97K |
| End cash Position | 107.49%145.18K | -13.05%294.71K | -10.54%287.97K | 35.03%33.04K | 35.03%33.04K | 194.04%69.97K | 349.42%338.95K | 196.48%321.9K | -3.17%24.47K | -3.17%24.47K |
| Free cash from | -102.86%-508.52K | -718.38%-104.06K | -38.06%176.88K | 94.75%-24.47K | -1.16%-76.2K | 45.28%-250.67K | 184.20%16.83K | 225.40%285.58K | 57.66%-465.62K | 51.38%-75.33K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.